With nearly 45% of Canadians expected to face cancer in their lifetime, Desjardins Insurance has launched Cancer Care Focus, a new initiative aimed at simplifying access to personalized support. The program partners with Calgary-born OncoHelix, Ottawa’s Constant Health, and New York–based Sword Health.
Desjardins will offer coverage for OncoHelix’s advanced biomarker testing, which helps identify tumour mutations and guide targeted therapies. Product Director Dr. Neda Nasseri says the goal is to meet members’ physical, emotional, and financial needs while improving early detection. Founded in 1900, Desjardins remains North America’s largest cooperative financial group.
Want to know more? Check out the source code on Calgary.tech.